SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.67 -0.51
(-0.53%)

EUR-INR

111.19 -0.10
(-0.09%)

GBP-INR

128.70 -0.19
(-0.14%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Newgen Software Technologies Ltd

Industry : Computers - Software - Medium / Small

BSE Code

ISIN Demat

Book Value()

540900

INE619B01017

114.7346246

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEWGEN

22.66

7187.76

EPS(TTM)

Face Value()

Div & Yield %

22.29

1.18

Back

Balaxi Pharmaceuticals consolidated net profit declines 95.42% in the September 2025 quarter

Nov 11,2025

Net profit of Balaxi Pharmaceuticals declined 95.42% to Rs 0.21 crore in the quarter ended September 2025 as against Rs 4.59 crore during the previous quarter ended September 2024. Sales declined 27.40% to Rs 56.18 crore in the quarter ended September 2025 as against Rs 77.38 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	56.18	77.38	-27
OPM %	2.06	13.69	-
PBDT	1.86	6.03	-69
PBT	1.38	5.56	-75
NP	0.21	4.59	-95

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.67 -0.51 (-0.53%)

111.19 -0.10 (-0.09%)

128.70 -0.19 (-0.14%)

0.60 0.00 (0.12%)